Bassam Wanna, MD
Clinical Cardiac Electrophysiology · Lacombe, LANPI 1265638639
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,073 of the $14,404 with a category attached, or 83.8%. 32 manufacturers reported payments, led by Medtronic at 38.0% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in LA, where the typical reported total is $18,132.
Across 279 payments — averaging $51.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Boston Scientific$2K
- Philips North America LLC$1K
- Janssen Research & Development, LLC$883
- Cook Medical LLC$506
- plus $2K from 26 others
What the payments were for
- Travel & lodging$2,24816%
- Food & beverage$12,07384%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 103 | $5,476 |
| Abbott | 65 | $2,432 |
| Boston Scientific | 22 | $1,587 |
| Philips North America LLC | 8 | $1,260 |
| Janssen Research & Development, LLC | 8 | $883 |
| Cook Medical LLC | 5 | $506 |
| Biosense Webster, Inc. | 7 | $492 |
| Shockwave Medical, Inc | 7 | $316 |
| Cardiofocus, Inc. | 4 | $255 |
| Abiomed | 9 | $234 |
| Edwards Lifesciences | 1 | $163 |
| Johnson & Johnson | 6 | $141 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $70 |
| Atricure, Inc. | 1 | $59 |
| Kestra Medical Technology Services, Inc. | 3 | $55 |
| Cardiva Medical, Inc. | 2 | $49 |
| Baxter Healthcare | 1 | $43 |
| Novo Nordisk | 2 | $39 |
| Amgen | 2 | $32 |
| Novartis | 1 | $30 |
| Amarin Pharma, Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Preventice Services, LLC | 1 | $22 |
| United Therapeutics Corporation | 1 | $21 |
| Livanova USA, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Baylis Medical Company Inc | 1 | $18 |
| Terumo Medical Corporation | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $13 |
| Biotronik Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,059
- (9124) LM Undivided$473
- IGT Devices Und$463
- Evolution$329
- Amplia MRI$323
- COBALT DR MRI SURESCAN$308
- ENSITE$289
- LUX-Dx Insertable Cardiac Monitor$285
- SelectSecure$279
- AURORA EV-ICD MRI SURESCAN$272
- S-ICD System Magnet$269
- Azure$231
- HeartLight System$183
- Reveal LINQ$180
- JOT DX$173
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$163
- Sprint Quattro$163
- Claria MRI$156
- AMPLIA MRI QUAD CRT-D SURESCAN$152
- Evera$150
How this compares
$14,404 in reported general payments places this provider in the 40th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $112,881 |
| XareltoRivaroxaban | 38 | $48,166 |
| EntrestoSacubitril/Valsartan | 15 | $20,311 |
| Dofetilide | 85 | $7,022 |
| Metoprolol Succinate | 128 | $1,687 |
| Amiodarone Hcl | 79 | $1,351 |
| Sucralfate | 14 | $629 |
| SotalolSotalol Hcl | 32 | $487 |
| Minocycline Hcl | 31 | $304 |
| Furosemide | 39 | $299 |
| Nebivolol Hcl | 13 | $284 |
| Potassium Chloride | 15 | $277 |
| Carvedilol | 16 | $246 |
| Sotalol AfSotalol Hcl | 16 | $175 |
| Atorvastatin Calcium | 15 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $141 | $48,16638 claims |
| NovartisEntresto | $30 | $20,31115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in Lacombe
- Nassir MarroucheNew Orleans$498K
- Sammy KhatibNew Orleans$115K
- Paul LelorierNew Orleans$101K
- Adil YousufNew Orleans$101K
- Mark PolletBaton Rouge$90K
- Joshua AymondBaton Rouge$64K
- Michael BernardNew Orleans$59K
- Dedric ClarkeNew Orleans$51K
- Eoin DonnellanLafayette$48K
- Glenn PolinNew Orleans$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.